The recent departure of Richard Moscicki from the US FDA’s Center for Drug Evaluation & Research shines a spotlight on the lack of an obvious succession plan for the top slot in CDER.
CDER Director Janet Woodcock has given no indication that she expects to retire from FDA any time soon. However, after...






